Praxis Pharmaceutical is a Madrid-based Spanish company that specialises in the commercial development of pharmaceuticals and medical devices intended for the advanced treatment of chronic wounds.
Founded in 2006, Praxis Pharmaceutical embarked upon its internationalisation in 2012 with the launch of Epiprot in Colombia. We now operate directly in Madrid and Bogotá through our commercial branches. Since the outset, our expansion has been underpinned by close collaboration with our local and regional partners, all of them specialists in their markets.
In 2017 we received the CE Mark to commercialise our innovative product Polyheal Micro.
PolyHeal Micro is a suspension of Negatively Charged Microspheres (NCM), a unique technology for wound management specially aimed to reactivate the healing process.
PolyHeal Micro, is a Medical Device Class IIb, manufactured in Spain, under the ISO 13485 and distributed through partners in different markets.
PolyHeal Micro is indicated for the treatment of ulcers of different etiologies and stagnant hard-to-heal wounds, including exposed bones and tendons without infection.
PolyHeal Micro reactivates the healing process and accelerates the formation of granulation tissue favouring closure. Tow outcomes can be expected after the application of Polyheal Micro:
PolyHeal® Micro is a single use, sterile suspension that is easy to apply by physicians, nurses, patient's family caregivers or the patients themselves, both in an in-patient or out-patient setting.
The safe, simple and effective administration of Polyheal Micro solves the challenge of chronic wounds management, reducing the expense in wound care and hospital burdens, and offers patients the possibility of a quicker return to a normal life.
